Inhibition of TNF-alpha by fibroblasts and fibroblast exosomes
AssigneeSpinalCyte, LLC
InventorsPete O'Heeron, Thomas Ichim
Life of this patent
Estimating the term…
Loading patent…
AssigneeSpinalCyte, LLC
InventorsPete O'Heeron, Thomas Ichim
Estimating the term…
Disclosed are means of suppressing production of the inflammatory cytokine TNF-alpha through contact-dependent and contact-independent means by fibroblast populations and products and/or derivatives of fibroblast populations. In one embodiment, fibroblasts are cultured under conditions allowing proliferation of said fibroblasts, wherein said proliferative status of fibroblasts correlates with the ability to directly suppress TNF-alpha production, and/or to release one or more factors capable of suppressing TNF-alpha production. In one embodiment, fibroblasts are used for treatment of inflammatory diseases by their ability to suppress TNF-alpha production. In other embodiments, conditioned media and/or exosomes of said fibroblasts are utilized to treat inflammatory diseases by their ability to suppress TNF-alpha production.
A method of suppressing production of TNF-alpha from a cell, comprising contacting cells capable of producing TNF-alpha with an effective amount of fibroblasts in a proliferated state and/or a conditioned medium generated by said fibroblasts, wherein the cells capable of producing TNF alpha are microglial cells and/or astrocyte cells.
Dependencies are inferred from the claim text.